Table 3.
Correlation between changes in inflammation and changes in lipid profile and baPWV values with adjustment for age, disease duration, blood pressure and medications.
SLEDAI | ESR | hsCRP | WBC | NLR | ||||||
Measurements | Corr | P | Corr | P | Corr | P | Corr | P | Corr | P |
TC | 0.10 | .49 | 0.21 | .15 | −0.02 | .90 | 0.02 | .88 | 0.09 | .52 |
LDL-C | 0.22 | .12 | −0.14 | .34 | 0 | .96 | 0.12 | .40 | 0.17 | .22 |
HDL-C | 0.11 | .43 | −0.04 | .77 | 0.27 | .06 | 0.05 | .71 | −0.01 | .93 |
TG | 0 | .95 | 0.33 | .02∗ | 0.05 | .76 | 0.01 | .92 | 0.22 | .13 |
TC/HDL-C | −0.11 | .46 | 0.24 | .10 | −0.20 | .16 | −0.07 | .62 | 0.12 | .40 |
baPWV | 0.36 | .01∗ | 0.19 | .19 | 0.22 | .12 | 0.10 | .47 | −0.10 | .49 |
Correlation analyses were performed with Spearman rank-order correlation test with adjustment for age, disease duration, changes in blood pressures (systolic blood pressure, diastolic blood pressure, mean arterial pressure and blood pressure), and changes in medications (prednisone dosage, hydroxychloroquine usage, cyclophosphamide usage, mycophenolate mofetil usage and ARB/ACEI usage).
p value < 0.05.
TC = total cholesterol, LDL-C = low-density lipoprotein cholesterol, HDL-C = high-density lipoprotein cholesterol, TG = triglyceride, TC/HDL-C = total cholesterol to high-density lipoprotein cholesterol ratio, baPWV = mean brachial-ankle pulse wave velocity, SLEDAI = systemic lupus erythematosus disease activity index, ESR = erythrocyte sedimentation rate, hsCRP = high sensitivity C-Reactive Protein, WBC = white blood cell, NLR = neutrophils/lymphocyte ratio.